Transition Preparation Intervention for Young Adults With Type 1 Diabetes
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
The purpose of this research study is to find out more about how to support young adults (ages 18-22) with type 1 diabetes as they prepare to transition from pediatric and adult endocrinology medical care.
Full description
The overarching goal of the proposed trial is to improve diabetes self-management and glycemic control in young adults and prepare them for the transition to adult endocrinology. The current application will investigate the impact of a multisystem transition preparation intervention for young adults (ages 18-22) with T1D. Twenty-five young adults and a parent will be enrolled in a 6-month transition preparation program which will use a hybrid in-person and technology delivery structure. Providers will receive training highlighting their role preparing young adults for transition and provides practical tips to use in their communication with young adults. If effective, this multisystem intervention, designed to enhance T1D self-management and increase young adults' readiness for transition to adult healthcare during this critical developmental period, has the potential to inform clinical practice guidelines.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Both members of the youth/parent dyad must meet all eligibility criteria
Young adults
- English-speaking
- patients in Pediatric Endocrinology at Children's Hospital of Richmond (CHoR) at Virginia Commonwealth University (VCU)
- between ages 18-22 yrs with a
- diagnosis of T1D for >1 year
Parents
- greater than 18 years of age
- provide care to the young adult with T1D
- are willing to participate in the intervention
Medical providers
• provide care to patients with T1D ages 18-22 yrs in Pediatric Endocrinology at CHoR
Exclusion criteria
Young adults
- significant psychiatric, cognitive, medical or developmental conditions that would impair their ability to complete assessments and/or engage in diabetes self-care behaviors (e.g., malignancies, psychosis, intellectual disability), as documented in the medical record or revealed during eligibility screening, or
- medically-induced diabetes or diagnosis of diabetes other than type 1 diabetes
Parents
- non-English speaking
- psychiatric, cognitive, or developmental conditions that would impair their ability to complete assessments and/or engage in the intervention as determined at study screening
Trial design
Primary purpose
Allocation
Interventional model
Masking
62 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal